Belpointe OZ Adjourns Annual Meeting to January 24, 2025 GREENWICH, CT, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Belpointe PREP, LLC (NYSE American: OZ) (“Belpointe OZ,” “we,” “us,” “our,” or the “Company”), the first publicly traded qualified opportunity fund,...

Akers Biosciences Prices $6,000,000 Public Offering THOROFARE, N.J, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or “Akers Bio”), a developer of rapid health information technologies, today...